Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany

被引：1

作者：

Kulp, W ^{[1
]}

Greiner, W ^{[1
]}

Schulenburg, JM ^{[1
]}

机构：

[1] Univ Hannover, Hannover, Germany

来源：

VALUE IN HEALTH | 2005年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)63062-8

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：392 / 393

页数：2

共 50 条

[1] Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
Fantino, Bruno
Moore, Nicholas
Verdoux, Helene
Auray, Jean-Paul
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 107 - 115
[2] Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany
Kulp, W
Hemels, M
Greiner, W
Graf, VDJ
VALUE IN HEALTH, 2005, 8 (06) : A210 - A210
[3] Escitalopram vs. venlafaxine XR treatment of major depressive disorder
Montgomery, S
Bielski, RJ
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S169 - S169
[4] Escitalopram vs venlafaxine XR treatment of major depressive disorder
Montgomery, SA
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S207 - S207
[5] Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey
Hemels, ME
Karamustafyoglu, O
Ozmen, E
Dilsad, S
Mene, S
VALUE IN HEALTH, 2005, 8 (03) : 392 - 392
[6] A cost-effectiveness analysis of escitalopram and sertraline in the treatment of major depressive disorder
Armstrong, EP
Skrepnek, GH
Malone, DC
Erder, H
VALUE IN HEALTH, 2005, 8 (03) : 393 - 393
[7] Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
Fernandez, JL
Montgomery, S
Francois, C
PHARMACOECONOMICS, 2005, 23 (02) : 155 - 167
[8] Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
José-Luis Fernandez
Stuart Montgomery
Clément Francois
PharmacoEconomics, 2005, 23 : 155 - 167
[9] Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
Mencacci, Claudio
Di Sciascio, Guido
Katz, Pablo
Ripellino, Claudio
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 87 - 99
[10] Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation
Llorca, P. M.
Fernandez, J. -L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (04) : 702 - 710

← 1 2 3 4 5 →